Synopsys, Inc. (NASDAQ:SNPS) Stock Position Increased by Xponance Inc.

Xponance Inc. raised its holdings in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 2.8% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,766 shares of the semiconductor company's stock after buying an additional 1,129 shares during the period. Xponance Inc.'s holdings in Synopsys were worth $19,786,000 at the end of the most recent reporting period.

Several other large investors have also modified their holdings of the business. Parnassus Investments LLC purchased a new stake in Synopsys during the third quarter worth $633,469,000. Edgewood Management LLC increased its position in shares of Synopsys by 18.9% during the third quarter. Edgewood Management LLC now owns 3,069,848 shares of the semiconductor company's stock worth $1,554,540,000 after purchasing an additional 487,025 shares in the last quarter. Raymond James Financial Inc. acquired a new position in shares of Synopsys in the 4th quarter valued at $199,065,000. Proficio Capital Partners LLC increased its position in shares of Synopsys by 71,578.5% in the 4th quarter. Proficio Capital Partners LLC now owns 386,347 shares of the semiconductor company's stock valued at $187,517,000 after acquiring an additional 385,808 shares during the period. Finally, Wellington Management Group LLP increased its position in shares of Synopsys by 32.5% in the 3rd quarter. Wellington Management Group LLP now owns 1,048,709 shares of the semiconductor company's stock valued at $531,056,000 after acquiring an additional 257,526 shares during the period. Hedge funds and other institutional investors own 85.47% of the company's stock.

Insider Buying and Selling

In other Synopsys news, CEO Sassine Ghazi sold 11,366 shares of the firm's stock in a transaction on Monday, March 3rd. The shares were sold at an average price of $463.75, for a total transaction of $5,270,982.50. Following the completion of the transaction, the chief executive officer now directly owns 70,922 shares of the company's stock, valued at $32,890,077.50. This trade represents a 13.81 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CRO Richard S. Mahoney sold 20,838 shares of the firm's stock in a transaction on Wednesday, January 15th. The stock was sold at an average price of $506.01, for a total transaction of $10,544,236.38. Following the transaction, the executive now directly owns 1,460 shares of the company's stock, valued at approximately $738,774.60. This represents a 93.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 47,909 shares of company stock valued at $22,794,835 in the last quarter. Company insiders own 0.62% of the company's stock.

Remove Ads

Synopsys Price Performance

NASDAQ:SNPS traded down $1.39 during trading hours on Friday, reaching $448.60. 3,362,089 shares of the company were exchanged, compared to its average volume of 1,021,710. The stock has a 50 day simple moving average of $491.19 and a 200 day simple moving average of $506.06. Synopsys, Inc. has a 52-week low of $425.73 and a 52-week high of $624.80. The firm has a market cap of $69.36 billion, a price-to-earnings ratio of 30.90, a PEG ratio of 3.23 and a beta of 1.16.

Analyst Upgrades and Downgrades

Several equities research analysts have commented on SNPS shares. Robert W. Baird lowered their price target on shares of Synopsys from $644.00 to $630.00 and set an "outperform" rating on the stock in a report on Thursday, December 5th. Redburn Atlantic began coverage on shares of Synopsys in a research note on Monday, January 13th. They issued a "buy" rating and a $600.00 price target on the stock. Needham & Company LLC reaffirmed a "buy" rating and issued a $650.00 price target on shares of Synopsys in a research note on Thursday, February 27th. Morgan Stanley cut their price objective on shares of Synopsys from $625.00 to $590.00 and set an "overweight" rating for the company in a report on Monday, February 24th. Finally, Rosenblatt Securities restated a "buy" rating and set a $660.00 price target on shares of Synopsys in a report on Tuesday, February 25th. One equities research analyst has rated the stock with a hold rating and eleven have assigned a buy rating to the company. Based on data from MarketBeat, Synopsys currently has an average rating of "Moderate Buy" and a consensus price target of $638.58.

Synopsys Company Profile

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.